Genetic studies in intellectual disability and behavioral impairment

Archives of Iranian Medicine

Volumn 19, Issue 5, 2016, Pages 363-375

  Mehregan, Hoda ^a   Najmabadi, Hossein ^a   Kahrizi, Kimia ^a  

^a UNIVERSITY OF SOCIAL WELFARE AND REHABILITATION SCIENCES   (Iran)

Author keywords

Behavioral impairment; Disorder; Genes; Intellectual disability

Indexed keywords

3 HYDROXYACYL COENZYME A DEHYDROGENASE; ANKYRIN 3; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE; DEFORMED EPIDERMAL AUTOREGULATORY FACTOR 1; DUAL SPECIFICITY PHOSPHATASE; GLUTAMATE RECEPTOR 3; INTERLEUKIN 1 RECEPTOR ACCESSORY PROTEIN; METHYL CPG BINDING PROTEIN 5; N DEACETYLASE N SULFOTRANSFERASE 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; NEUREXIN; NEUROLIGIN; OLIGOPHRENIN 1; P21 ACTIVATED KINASE 3; POSTSYNAPTIC DENSITY PROTEIN 95; PROTEIN; PROTEIN PATCHED 1; RETINOBLASTOMA BINDING PROTEIN 2; RHO GUANINE NUCLEOTIDE DISSOCIATION INHIBITOR 1; RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 6; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG;

AGGRESSION; ANGER; ATTENTION DEFICIT DISORDER; AUTISM; AUTOMUTILATION; BEHAVIOR DISORDER; CHILDHOOD DISEASE; CHROMOSOME DELETION; CHROMOSOME DUPLICATION; DEVELOPMENTAL DISORDER; DROSOPHILA; FRAGILE X SYNDROME; GENE EXPRESSION; GENE MUTATION; GENETIC DISORDER; GLUTAMATERGIC SYNAPSE; HAPPY PUPPET SYNDROME; HUMAN; HYPERACTIVITY; INTELLECTUAL IMPAIRMENT; META ANALYSIS (TOPIC); NONHUMAN; OBSESSIVE COMPULSIVE DISORDER; OPPOSITIONAL DEFIANT DISORDER; PRADER WILLI SYNDROME; PROTEIN EXPRESSION; REVIEW; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; ANIMAL; COMPLICATION; DISEASE MODEL; GENETICS; MENTAL DISEASE; MOUSE;

ANIMALS; DISEASE MODELS, ANIMAL; DROSOPHILA; HUMANS; INTELLECTUAL DISABILITY; MENTAL DISORDERS; MICE; SIGNAL TRANSDUCTION;

EID: 84965002240     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Review

References (160)

1. Maulik PK, Mascarenhas MN, Mathers CD, Dua T, Saxena S. Prevalence of intellectual disability: a meta-analysis of population-based studies. Research in Developmental Disabilities. 2011; 32(2): 419 - 436.
2. Schalock RL, Borthwick-Duffy SA, Bradley VJ, Buntinx WH, Coulter DL, Craig EM, et al. Intellectual disability: Definition, classification, and systems of supports: ERIC. American Association on Intellectual and Developmental Disabilities. 2010; ERIC Number: ED509596.
3. Kaufman L, Ayub M, Vincent JB. The genetic basis of non-syndromic intellectual disability: A review. Journal of Neurodevelopmental Disorders. 2010; 2(4): 182-209.
4. Ropers H-H, Hamel BC. X-linked mental retardation. Nature Reviews Genetics. 2005; 6(1): 46-57.
5. Ropers HH. Genetics of early onset cognitive impairment. Annual Review of Genomics and Human Genetics. 2010: 11: 161-187.
6. Sweatt JD. Pitt-Hopkins Syndrome: intellectual disability due to loss of TCF4-regulated gene transcription. Experimental & Molecular Medicine. 2013; 45(5): e21.
7. Ropers F, Delivery E, Hu H, Garshasbi M, Karbasiyan M, Herold M, et al. Identification of a novel candidate gene for non-syndromic autosomal recessive intellectual disability: the WASH complex member SWIP. Human Molecular Genetics. 2011; 20(13): 2585 -2590.
8. Chelly J, Khelfaoui M, Francis F, Chérif B, Bienvenu T. Genetics and pathophysiology of mental retardation. European Journal of Human Genetics. 2006; 14(6): 701-713.
9. Nestler EJ, Hyman SE. Animal models of neuropsychiatric disorders. Nature neuroscience. 2010; 13(10): 1161-9.
10. Moreno-De-Luca A, Myers SM, Challman TD, Moreno-De-Luca D, Evans DW, Ledbetter DH. Developmental brain dysfunction: revival and expansion of old concepts based on new genetic evidence. The Lancet Neurology. 2013; 12(4): 406-414.
11. Di Nuovo SF, Buono S. Psychiatric syndromes comorbid with mental retardation: differences in cognitive and adaptive skills. Journal of Psychiatric Research. 2007; 41(9): 795 -800.
12. Deb S, Thomas M, Bright C. Mental disorder in adults with intellectual disability. 1: Prevalence of functional psychiatric illness among a community-based population aged between 16 and 64 years. Journal of Intellectual Disability Research. 2001; 45(6): 495 - 505.
13. Stromme P. Diseth TH. Prevalence of psychiatric diagnoses in children with mental retardation: data from a population-based study. Developmental Medicine & Child Neurology. 2000; 42(04): 266 - 270.
14. McClintock K, Hall S, Oliver C. Risk markers associated with challenging behaviours in people with intellectual disabilities: A meta-analytic study. Journal of Intellectual Disability Research. 2003; 47(6): 405-416.
15. Lindblad I, Gillberg C, Fernell E. ADHD and other associated developmental problems in children with mild mental retardation. The use of the "Five-To-Fifteen" questionnaire in a population-based sample. Research in Developmental Disabilities. 2011; 32(6): 2805 -2809.
16. Jauhari P. Bhargava R Bhave A, Kumar C, Kumar R. Comorbidities associated with intellectual disability among pediatric outpatients seen at a teaching hospital in northern india. Journal of Policy and Practice in Intellectual Disabilities. 2012; 9(1): 10 - 16.
17. Simonoff E, Pickles A, Wood N, Gringras P. Chadwick O. ADHD symptoms in children with mild intellectual disability. Journal of the American Academy of Child & Adolescent Psychiatry. 2007; 46(5): 591-600.
18. Dekker MC, Koot HM. DSM-IV disorders in children with borderline to moderate intellectual disability. I: Prevalence and impact. Journal of the American Academy of Child & Adolescent Psychiatry. 2003; 42(8): 915-922.
19. Matson JL, Shoemaker M. Intellectual disability and its relationship to autism spectrum disorders. Research in Developmental Disabilities. 2009; 30(6): 1107-1114.
20. Srivastava AK, Schwartz CE. Intellectual disability and autism spectrum disorders: Causal genes and molecular mechanisms. Neuroscience & Biobehavioral Reviews. 2014; 46: 161 - 174.
21. Vig S, Jedrysek E. Autistic features in young children with significant cognitive impairment: Autism or mental retardation? Journal of Autism and Developmental Disorders. 1999; 29(3): 235 -248.
22. Matson JL, Cooper C, Malone CJ, Moskow SL. The relationship of self-injurious behavior and other maladaptive behaviors among individuals with severe and profound intellectual disability. Research in Developmental Disabilities. 2008; 29(2): 141 - 148.
23. Nyberg L, Lövdén M, Riklund K Lindenberger U, Bäckman L. Memory aging and brain maintenance. Trends in Cognitive Sciences. 2012; 16(5): 292-305.
24. Barresi S, Tomaselli S, Athanasiadis A, Galeano F, Locatelli F, Bertini E, et al. Oligophrenin-1 (OPHN1), a Gene Involved in X-Linked Intellectual Disability Undergoes RNA Editing and Alternative Splicing during Human Brain Development. PloS One. 2014; 9(3): e91351.
25. Najmabadi H, Hu H, Garshasbi M, Zemojtel T, Abedini SS, Chen W, et al. Deep sequencing reveals 50 novel genes for recessive cognitive disorders. Nature. 2011; 478(7367): 57 -63.
26. Study TDDD. Large-scale discovery of novel genetic causes of developmental disorders. Nature. 2015; 519(7542): 223 -228.
27. Ellison JW, Rosenfeld JA, Shaffer LG. Genetic basis of intellectual disability. Annual Review of Medicine. 2013; 64: 441 -450.
28. Huber KM, Gallagher SM, Warren ST, Bear MF. Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proceedings of the National Academy of Sciences. 2002; 99(11): 7746 - 7750.
29. Kotlar AV, Mercer KB, Zwick ME, Mulle JG. New discoveries in schizophrenia genetics reveal neurobiological pathways: A review of recent findings. European journal of medical genetics. 2015; 58(12): 704 - 714.
30. Kirov G, Rees E, Walters JT, Escott-Price V, Georgieva L, Richards AL, et al. The penetrance of copy number variations for schizophrenia and developmental delay. Biological Psychiatry. 2014; 75(5): 378 - 385.
31. Myers BA Pueschel SM. Psychiatric disorders in persons with Down syndrome. The Journal of Nervous and Mental Disease. 1991; 179(10): 609-613.
32. Ekstein S, Glick B, Weill M, Kay B, Berger I. Down syndrome and attention-deficit/hyperactivity disorder (ADHD). Journal of Child Neurology. 2011; 26(10): 1290 - 1295.
33. Dykens EM, Leckman JF, Cassidy SB. Obsessions and compulsions in Prader-Willi syndrome. Journal of Child Psychology and Psychiatry. 1996; 37(8): 995-1002.
34. Steffenburg S, Gillberg CL, Steffenburg U, Kyllerman M. Autism in Angelman syndrome: a population-based study. Pediatric Neurology. 1996; 14(2): 131 - 136.
35. Summers JA, Allison D, Lynch P, Sandier L. Behaviour problems in Angelman syndrome. Journal of Intellectual Disability Research. 1995; 39(2): 97-106.
36. Rogers SJ, Wehner EA Hagerman R. The behavioral phenotype in fragile X: symptoms of autism in very young children with fragile X syndrome, idiopathic autism, and other developmental disorders. Journal of Developmental & Behavioral Pediatrics. 2001; 22(6): 409 -417.
37. Garber KB, Visootsak J, Warren ST. Fragile X syndrome. European Journal of Human Genetics. 2008; 16(6): 666-72.
38. Hall SS, Lightbody AA Reiss AL. Compulsive, self-injurious, and autistic behavior in children and adolescents with fragile X syndrome. Journal Information. 2008; 113(1): 44-53.
39. Hessl D, Tassone F, Cordeiro L, Koldewyn K McCormick C, Green C, et al. Brief report: Aggression and stereotypic behavior in males with fragile X syndrome-Moderating secondary genes in a "single gene" disorder. Journal of Autism and Developmental Disorders. 2008; 38(1): 184-189.
40. McNaughton CH, Moon J, Strawderman MS, Maclean KN, Evans J, Strupp BJ. Evidence for social anxiety and impaired social cognition in a mouse model of fragile X syndrome. Behavioral Neuroscience. 2008; 122(2): 293.
41. Orrico A Galli L, Buoni S, Hayek G, Luchetti A, Lorenzini S, et al. Attention-deficit'hyperactivity disorder (ADHD) and variable clinical expression of Aarskog-Scott syndrome due to a novel FGD1 gene mutation (R408Q). American Journal of Medical Genetics Part A. 2005; 135(1): 99-102.
42. Orrico A Galli L, Cavaliere ML, Garavelli L, Fryns J-P, Crashell E, et al. Phenotypic and molecular characterisation of the Aarskog-Scott syndrome: a survey of the clinical variability in light of FGD1 mutation analysis in 46 patients. European Journal of Human Genetics. 2004; 12(1): 16-23.
43. Graham JM, Supemeau D, Rogers RC, Corning K, Schwartz CE, Dykens EM. Clinical and behavioral characteristics in FG syndrome. American Journal of Medical Genetics. 1999; 85(5): 470-475.
44. Piluso G, D'Amico F, Saccone V, Bismuto E, Rotundo IL, Di Domenico M, et al. Amissense mutation in CASK causes FG syndrome in an Italian family. The American Journal of Human Genetics. 2009; 84(2): 162-177.
45. Talkowski ME, Mullegama SV, Rosenfeld JA van Bon BW, Shen Y, Repnikova EA, et al. Assessment of 2q23. 1 microdeletion syndrome implicates MBD5 as a single causal locus of intellectual disability, epilepsy, and autism spectrum disorder. The American Journal of Human Genetics. 2011; 89(4): 551 - 563.
46. Van Bon BW, Koolen DA, Brueton L, McMullan D, Lichtenbelt KD, Adès LC, et al. The 2q23. 1 microdeletion syndrome: clinical and behavioural phenotype. European Journal of Human Genetics. 2010; 18(2): 163-170.
47. Mullegama SV, Rosenfeld JA, Orellana C, van Bon BW, Halbach S, Repnikova EA, et al. Reciprocal deletion and duplication at 2q23. 1 indicates a role for MBD5 in autism spectrum disorder. European Journal of Human Genetics. 2014; 22(1): 57 - 63.
48. Bonnet C, Khan AA Bresso E, Vigouroux C, Béri M, Lejczak S, et al. Extended spectrum of MBD5 mutations in neurodevelopmental disorders. European Journal of Human Genetics. 2013; 21(12): 1457 -1461.
49. Risheg H, Graham JM, Clark RD, Rogers RC, Opitz JM, Moeschler JB, et al. A recurrent mutation in MED12 leading to R961W causes Opitz-Kaveggia syndrome. Nature Genetics. 2007; 39(4): 451 - 453.
50. du Souich C, Chou A Ym J, Oh T, Nelson TN, Hurlburt J, et al. Characterization of a new X-linked mental retardation syndrome with microcephaly, cortical malformation, and thin habitus. American Journal of Medical Genetics Part A. 2009; 149(11): 2469-2478.
51. Bmnetti-Pierri N, Berg JS, Scaglia F, Belmont J, Bacino CA Sahoo T, et al. Recurrent reciprocal lq21. 1 deletions and duplications associated with microcephaly or macrocephaly and developmental and behavioral abnormalities. Nature Genetics. 2008; 40(12): 1466 - 1471.
52. Shinawi M, Liu P, Kang SHL, Shen J, Belmont JW, Scott DA et al. Recurrent reciprocal 16p11. 2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size. Journal of Medical Genetics. 2010; 47(5): 332-341.
53. Nizon M, Andrieux J, Rooryck C, de Blois MC, Bourel-Ponchel E, Bourgois B, et al. Phenotype-genotype correlations in 17 new patients with an Xpl1.23pl1. 22 microduplication and review of the literature. American Journal of Medical Genetics Part A. 2015; 167(1): 111 -22.
54. Poirier R, Jacquot S, Vaillend C, Soutthiphong A Libbey M, Davis S, et al. Deletion of the Coffin-Lowry syndrome gene Rsk2 in mice is associated with impaired spatial learning and reduced control of exploratory behavior. Behavior Genetics. 2007; 37(1): 31 - 50.
55. Matsumoto A, Kuwajima M. Miyake K, Kojima K. Nakashima N. Jimbo EF. et al. An Xp22. 12 microduplication including RPS6KA3 identified in a family with variably affected intellectual and behavioral disabilities. Journal of Human Genetics. 2013; 58(11): 755 - 757.
56. Gandomi SK. Gonzalez KF. Parra M. Shahmirzadi L. Mancuso J, Pichurin P. et al. Diagnostic exome sequencing identifies two novel IQ- SEC2 mutations associated with X-linked intellectual disability with seizures: implications for genetic counseling and clinical diagnosis. Journal of Genetic Counseling. 2014; 23(3): 289 - 298.
57. Fieremans N. Van Esch H. de Ravel T. Van Driessche J, Belet S, Bauters M, et al. Microdeletion of the escape genes KDM5C and IQ- SEC2 in a girl with severe intellectual disability and autistic features. European Journal of Medical Genetics. 2015; 58(5): 324 - 327.
58. Turner G. Partington M. Kerr B. Mangelsdorf M. Gecz J. Variable expression of mental retardation, autism, seizures, and dystonic hand movements in two families with an identical ARX gene mutation. American Journal of Medical Genetics. 2002; 112(4): 405-411.
59. Partington M, Turner G, Boyle J, Gecz J. Three new families with X- linked mental retardation caused by the 428-451dup (24bp) mutation in ARX. Clinical Genetics. 2004; 66(1): 39-45.
60. Szczaluba K Nawara M, Poirier K, Pilch J, Gajdulewicz M, Spodar K, et al. Genotype-phenotype associations for ARX gene duplication in X-linked mental retardation. Neurology. 2006; 67(11): 2073 - 2075.
61. Chaste P, Nygren G, Anckarsäter FI, Råstam M, Coleman M, Leboyer M, et al. Mutation screening of the ARX gene in patients with autism. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 2007; 144(2): 228-30.
62. Kahrizi K, Najmabadi FI. Genetics of Recessive Cognitive Disorders. eLS. DOI: 10.1002/9780470015902.a0025835.
63. Frankie WG, Lemia J, Laraelle M. The synaptic hypothesis of schizophrenia. Neuron. 2003; 39(2): 205 -216.
64. Nithianantharajah J, Flamian A. Dysregulation of synaptic proteins, dendritic spine abnormalities and pathological plasticity of synapses as experience-dependent mediators of cognitive and psychiatric symptoms in Huntington's disease. Neuroscience. 2013; 251: 66 - 74.
65. Zoghbi HY, Bear MF. Synaptic dysfunction in neurodevelopmental disorders associated with autism and intellectual disabilities. Cold Spring Harbor Perspectives in Biology. 2012; 4(3): a009886.
66. Waltereit R, Banaschewski T, Meyer-Lindenberg A, Poustka L. Interaction of neurodevelopmental pathways and synaptic plasticity in mental retardation, autism spectrum disorder and schizophrenia: Implications for psychiatry. The World Journal of Biological Psychiatry. 2014; 15(7): 507-516.
67. Toro R Konyukh M, Delorme R, Leblond C, Chaste P, Fauchereau F, et al. Key role for gene dosage and synaptic homeostasis in autism spectrum disorders. Trends in Genetics. 2010; 26(8): 363 - 372.
68. Betancur C, Sakurai T, Buxbaum JD. The emerging role of synaptic cell-adhesion pathways in the pathogenesis of autism spectrum disorders. Trends in Neurosciences. 2009; 32(7): 402 - 412.
69. Chechlacz M, Gleeson JG. Is mental retardation a defect of synapse structure and function? Pediatric Neurology. 2003; 29(1): 11-17.
70. Hutsler JJ, Zhang H. Increased dendritic spine densities on cortical projection neurons in autism spectrum disorders. Brain Research. 2010; 1309: 83-94.
71. Kaufmann WE, Moser HW. Dendritic anomalies in disorders associated with mental retardation. Cerebral cortex. 2000; 10(10): 981 -991.
72. Blanpied TA Ehlers MD. Microanatomy of dendritic spines: emerging principles of synaptic pathology in psychiatric and neurological disease. Biological Psychiatry. 2004; 55(12): 1121 - 1127.
73. Kulkami VA, Firestein BL. The dendritic tree and brain disorders. Molecular and Cellular Neuroscience. 2012; 50(1): 10-20.
74. Penzes P, Cahill ME, Jones KA, VanLeeuwen JE, Woolfrey KM. Dendritic spine pathology in neuropsychiatric disorders. Nature Neuroscience. 2011; 14(3): 285 - 293.
75. Ryglewski S, Kadas D, Hutchinson K, Schuetzler N, Vonhoff F, Duch C. Dendrites are dispensable for basic motoneuron function but essential for fine tuning of behavior. Proceedings of the National Academy of Sciences. 2014; 111(50): 18049-18054.
76. Chadman KK, Gong S, Scattoni ML, Boltuck SE, Gandhy SU, Heintz N. et al. Minimal aberrant behavioral phenotypes of neuroligin-3 R451C knockin mice. Autism Research. 2008; 1(3): 147 - 158.
77. Bourgeron T. The possible interplay of synaptic and clock genes in autism spectrum disorders. Cold Spring harbor symposia on quantitative biology. 2007: Cold Spring Harbor Laboratory Press; 2007; 645-654.
78. Laumonnier F, Bonnet-Brilhault F, Gomot M, Blanc R David A Moizard M-P, et al. X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. The American Journal of Human Genetics. 2004; 74(3): 552 - 557.
79. Sato D, Lionel AC, Leblond CS, Prasad A Pinto D, Walker S, et al. SHANK1 deletions in males with autism spectrum disorder. The American Journal of Human Genetics. 2012; 90(5): 879 - 887.
80. Berkel S, Marshall CR, Weiss B, Howe J, Roeth R Moog U, et al. Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation. Nature Genetics. 2010; 42(6): 489-491.
81. Durand CM, Betancur C, Boeckers TM, Bockmann J, Chaste P, Fauchereau F, et al. Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders. Nature Genetics. 2007; 39(1): 25 - 27.
82. Miles JH. Autism spectrum disorders-a genetics review. Genetics in Medicine. 2011; 13(4): 278-294.
83. Jiang YH, Ehlers MD. Modeling autism by SHANK gene mutations in mice. Neuron. 2013; 78(1): 8 - 27.
84. Guilmatre A Huguet G, Delorme R Bourgeron T. The emerging role of SHANK genes in neuropsychiatric disorders. Developmental Neurobiology. 2014; 74(2): 113 - 122.
85. Ting JT, Peça J, Feng G. Functional consequences of mutations in postsynaptic scaffolding proteins and relevance to psychiatric disorders. Annual Review of Neuroscience. 2012; 35: 49 -71.
86. Quintero-Rivera F, Sharifi-Hannauer P, Martinez-Agosto JA. Autistic and psychiatric findings associated with the 3q29 microdeletion syndrome: case report and review. American Journal of Medical Genetics Part A. 2010; 152(10): 2459-2467.
87. Mulle JG. Dodd AF. McGrath JA Wolyniec PS. Mitchell AA Shetty AC, et al. Microdeletions of 3q29 confer high risk for schizophrenia. The American Journal of Human Genetics. 2010; 87(2): 229-236.
88. Carroll LS. Williams HJ. Walters J. Kirov G. O'Donovan MC. Owen MJ. Mutation screening of the 3q29 microdeletion syndrome candidate genes DLG1 and PAK2 in schizophrenia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 2011; 156(7): 844-849.
89. Tarpey P. Pamau J. Blow M. Woffendin H. Bignell G. Cox C. et al. Mutations in the DLG3 gene cause nonsyndromic X-linked mental retardation. The American Journal of Human Genetics. 2004; 75(2): 318-324.
90. Kantojärvi K Kotala I. Rehnström K. Ylisaukko-oja T. Vanhala R von Wendt TN, et al. Fine mapping of Xq11. 1-q21. 33 and mutation screening of RPS6KA6. ZNF711. ACSL4. DLG3. and IL1RAPL2 for autism spectrum disorders (ASD). Autism Research. 2011; 4(3): 228 -233.
91. Feyder M. Karlsson R-M. Mathur P. Lyman M. Bock R. Momenan R et al. Association of mouse Dlg4 (PSD-95) gene deletion and human DLG4 gene variation with phenotypes relevant to autism spectrum disorders and Williams' syndrome. American Journal of Psychiatry. 2010; 167(12): 1508-1517.
92. Liston C. Miller MM. Goldwater DS. Radley JJ. Rocher AB. Hof PR. et al. Stress-induced alterations in prefrontal cortical dendritic morphology predict selective impairments in perceptual attentional set- shifting. The Journal of Neuroscience. 2006; 26(30): 7870 - 7874.
93. Popoli M. Yan Z. McEwen BS. Sanacora G. The stressed synapse: the impact of stress and glucocorticoids on glutamate transmission. Nature Reviews Neuroscience. 2012; 13(1): 22-37.
94. Owen MJ. O'Donovan MC. Harrison PJ. Schizophrenia: a genetic disorder of the synapse?: Glutamatergic synapses might be the site of primary abnormalities. BMJ: British Medical Journal. 2005; 330(7484): 158.
95. Abrahams BS. Geschwind DH. Advances in autism genetics: on the threshold of a new neurobiology. Nature Reviews Genetics. 2008; 9(5): 341 -355.
96. Hamdan FF, Gauthier J, Araki Y, Lin D-T, Yoshizawa Y, Higashi K, et al. Excess of de novo deleterious mutations in genes associated with glutamatergic systems in nonsyndromic intellectual disability. The American Journal of Human Genetics. 2011; 88(3): 306 - 316.
97. Hu W. MacDonald ML. Elswick DE. Sweet RA. The glutamate hy pothesis of schizophrenia: evidence from human brain tissue studies. Annals of the New York Academy of Sciences. 2015; 1338(1): 38-57.
98. Wilson GM. Flibotte S. Chopra V. Melnyk BL. Honer WG Holt RA. DNA copy-number analysis in bipolar disorder and schizophrenia reveals aberrations in genes involved in glutamate signaling. Human Molecular Genetics. 2006; 15(5): 743 - 749.
99. Meldram BS. Glutamate as a neurotransmitter in the brain: review of physiology and pathology. The Journal of Nutrition. 2000; 130(4): 1007S - 1015S.
100. Pin J-P, Duvoisin R. The metabotropic glutamate receptors: structure and functions. Neuropharmacology. 1995; 34(1): 1 -26.
101. D'Antoni S, Spatuzza M, Bonaccorso CM, Musumeci SA Ciranna L, Nicoletti F, et al. Dysregulation of group-I metabotropic glutamate (mGlu) receptor mediated signalling in disorders associated with Intellectual Disability and Autism. Neuroscience & Biobehavioral Reviews. 2014; 46:228 - 241.
102. Soto D, Altafaj X, Sindreu C, Bayés A. Glutamate receptor mutations in psychiatric and neurodevelopmental disorders. Communicative & Integrative Biology. 2014; 7(1): e27887.
103. Motazacker MM, Rost BR Hucho T, Garshasbi M, Kahrizi K, Ullmann R, et al. A defect in the ionotropic glutamate receptor 6 gene (GRIK2) is associated with autosomal recessive mental retardation. The American Journal of Human Genetics. 2007; 81(4): 792 - 798.
104. Sampaio AS, Fagemess J, Crane J, Leboyer M, Delorme R, Pauls DL, et al. Association Between Polymorphisms in GRIK2 Gene and Obsessive-Compulsive Disorder: A Family-Based Study. CNS Neuroscience & Therapeutics. 2011; 17(3): 141 - 147.
105. Wang K, Zhang H, Ma D, Bucan M, Glessner JT, Abrahams BS, et al. Common genetic variants on 5pl4. 1 associate with autism spectrum disorders. Nature. 2009; 459(7246): 528 - 533.
106. Tarabeux J, Kebir O, Gauthier J, Hamdan F, Xiong L, Piton A, et al. Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia. Translational Psychiatry. 2011; 1(11): e55.
107. Qin S, Zhao X Pan Y. Liu J, Feng G, Fu J, et al. An association study of the N-methyl-D-aspartate receptor NR1 subunit gene (GRIN1) and NR2B subunit gene (GRIN2B) in schizophrenia with universal DNA microarray. European Journal of Human Genetics. 2005; 13(7): 807 -814.
108. Galehdari H. Association between the G1001C polymorphism in the GRIN1 gene promoter and schizophrenia in the Iranian population. Journal of Molecular Neuroscience. 2009; 38(2): 178 - 181.
109. Zhao X Li H, Shi Y, Tang R, Chen W, Liu J, et al. Significant association between the genetic variations in the 5' end of the N-methyl-D- aspartate receptor subunit gene GRIN1 and schizophrenia. Biological Psychiatry. 2006; 59(8): 747 - 753.
110. Hamdan IFF, Srour M, Capo-Chichi JM, Daoud H, Nassif C, Patry L, et al. De novo mutations in moderate or severe intellectual disability. PLoS Genet. 2014; 10(10): e1004772.
111. Smith KR, Kopeikina KJ, Fawcett-Patel JM, Leaderbrand K, Gao R Schürmann B, et al. Psychiatric risk factor ANK3/ankyrin-G nanodomains regulate the structure and function of glutamatergic synapses. Neuron. 2014; 84(2): 399-415.
112. Imbrici P, Camerino DC, Tricarico D. Major channels involved in neuropsychiatric disorders and therapeutic perspectives. Frontiers in Genetics. 2013; 4: 76.
113. Iqbal Z, Vandeweyer G, van der Voet M, Waryah AM, Zahoor MY, Besseling JA, et al. Homozygous and heterozygous disruptions of ANK3: at the crossroads of neurodevelopmental and psychiatric disorders. Human Molecular Genetics. 2013; 22(10): 1960 - 1970.
114. Noor A Whibley A Marshall CR, Gianakopoulos PJ, Piton A Carson AR, et al. Disruption at the PTCHD1 Locus on Xp22. 11 in Autism spectrum disorder and intellectual disability. Science Translational Medicine. 2010; 2(49): 49ra68 - 49ra68.
115. Filges I, Röthlisberger B, Blattner A, Boesch N, Demougin P, Wenzel F, et al. Deletion in Xp22. 11: PTCHD1 is a candidate gene for X- linked intellectual disability with or without autism. Clinical Genetics. 2011; 79(1): 79-85.
116. Carter M, Nikkei S, Fernandez B, Marshall C, Noor A, Lionel A et al. Hemizygous deletions on chromosome lp21. 3 involving the DPYD gene in individuals with autism spectrum disorder. Clinical Genetics. 2011; 80(5): 435-443.
117. Torrico B, Fernàndez-Castillo N, Hervás A, Milà M, Salgado M, Rueda I, et al. Contribution of common and rare variants of the PTCHD1 gene to autism spectrum disorders and intellectual disability. Eur J Hum Genet. 2015; 23(12): 1694 - 1701.
118. Molinari F, Foulquier F, Tarpey PS, Morelle W, Boissel S, Teague J, et al. Oligosaccharyltransferase-subunit mutations in nonsyndromic mental retardation. The American Journal of Human Genetics. 2008; 82(5): 1150-1157.
119. Garshasbi M, Hadavi V, Habibi H, Kahrizi K, Kariminejad R, Behjati F, et al. A defect in the TUSC3 gene is associated with autosomal recessive mental retardation. The American Journal of Human Genetics. 2008; 82(5): 1158-1164.
120. Garshasbi M, Kahrizi K, Hosseini M, Nouri Vahid L, Falah M, Hemmati S, et al. A novel nonsense mutation in TUSC3 is responsible for non-syndromic autosomal recessive mental retardation in a consanguineous Iranian family. American Journal of Medical Genetics Part A. 2011; 155(8): 1976-1980.
121. Loddo S, Parisi V, Doccini V, Filippi T, Bemardini L, Brovedani P, et al. Homozygous deletion in TUSC3 causing syndromic intellectual disability: a new patient. American Journal of Medical Genetics Part A. 2013; 161(8): 2084 - 2087.
122. Salomons G, Van Dooren S, Verhoeven N, Marsden D, Schwartz C, Cecil K, et al. X-linked creatine transporter defect: an overview. Journal of Inherited Metabolic Disease. 2003; 26(2-3): 309 - 318.
123. Hahn KA, Salomons GS, Tackels-Home D, Wood TC, Taylor HA, Schroer RJ, et al. X-linked mental retardation with seizures and carrier manifestations is caused by a mutation in the creatine-transporter gene (SLC6A8) located in Xq28. The American Journal of Human Genetics. 2002; 70(5): 1349 - 1356.
124. Rosenberg EH, Almeida LS, Kleefstra T, Yntema HG, Bahi N, Moraine C, et al. High prevalence of SLC6A8 deficiency in X-linked mental retardation. The American Journal of Human Genetics. 2004; 75(1): 97-105.
125. Nasrallah F, Feki M, Kaabachi N. Creatine and creatine deficiency syndromes: biochemical and clinical aspects. Pediatric Neurology. 2010; 42(3): 163-171.
126. Iqbal Z, Willemsen MH, Papon M-A, Musante L, Benevento M, Hu H, et al. Homozygous SLC6A17 Mutations Cause Autosomal-Recessive Intellectual Disability with Progressive Tremor, Speech Impairment, and Behavioral Problems. The American Journal of Human Genetics. 2015; 96(3): 386 - 396.
127. Ba W, van der Raadt J, Kasri NN. Rho GTPase signaling at the synapse: implications for intellectual disability. Experimental Cell Research. 2013; 319(15): 2368-2374.
128. Verpelli C, Sala C. Molecular and synaptic defects in intellectual disability syndromes. Current Opinion in Neurobiology. 2012; 22(3): 530 - 536.
129. Govek E-E, Newey SE, Akerman CJ, Cross JR Van der Veken L, Van Aelst L. The X-linked mental retardation protein oligophrenin-1 is required for dendritic spine morphogenesis. Nature Neuroscience. 2004; 7(4): 364 - 372.
130. Khelfaoui M, Denis C, Van Galen E, De Bock F, Schmitt A Houbron C, et al. Loss of X-linked mental retardation gene oligophreninl in mice impairs spatial memory and leads to ventricular enlargement and dendritic spine immaturity. The Journal of Neuroscience. 2007; 27(35): 9439-9450.
131. Shimojima K, Sugawara M, Shichiji M, Mukaida S, Takayama R, Imai K, et al. Loss-of-function mutation of collybistin is responsible for X-linked mental retardation associated with epilepsy. Journal of Human Genetics. 2011; 56(8): 561 - 565.
132. Lesca G, Till M, Labalme A, Vallee D, Hugonenq C, Philip N, et al. De novo Xq11.11 microdeletion including ARHGEF9 in a boy with mental retardation, epilepsy, macrosomia, and dysmorphic features. American Journal of Medical Genetics Part A. 2011; 155(7): 1706 -1711.
133. Kalscheuer VM, Musante L, Fang C, Hoffmann K, Fuchs C, Carta E, et al. A balanced chromosomal translocation disrupting ARHGEF9 is associated with epilepsy, anxiety, aggression, and mental retardation. Human Mutation. 2009; 30(1): 61 -68.
134. Hayashi T, Yoshida T, Ra M, Taguchi R Mishina M. IL1RAPL1 associated with mental retardation and autism regulates the formation and stabilization of glutamatergic synapses of cortical neurons through RhoA signaling pathway. 2013.
135. Piton A, Michaud JL, Peng H, Aradhya S, Gauthier J, Mottron L, et al. Mutations in the calcium-related gene IL1RAPL1 are associated with autism. Human Molecular Genetics. 2008; 17(24): 3965 - 3974.
136. Nawara M, Klapecki J, Borg K, Jurek M, Moreno S, Tryfon J, et al. Novel mutation of IL1RAPL1 gene in a nonspecific X-linked mental retardation (MRX) family. American Journal of Medical Genetics Part A. 2008; 146(24): 3167 - 3172.
137. Allen-Brady K, Cai G, Camion D, Robison R McMahon WM, Coon H, et al. No evidence for IL1RAPL1 involvement in selected high-risk autism pedigrees from the AGRE data set. Autism Research. 2011; 4(4): 293-296.
138. Franek KJ. Butler J, Johnson J, Simensen R Friez MJ, Bartel F, et al. Deletion of the immunoglobulin domain of IL1RAPL1 results in nonsyndromic X-linked intellectual disability associated with behavioral problems and mild dysmorphism. American Journal of Medical Genetics Part A. 2011; 155(5): 1109-1114.
139. Noor A. Molecular Genetic Study of Autism and Intellectual Disability genes on the X-Chromosome: University of Toronto; 2012.
140. Yamamoto T, Wilsdon A Joss S, Isidor B, Erlandsson A Suri M, et al. An emerging phenotype of Xq22 microdeletions in females with severe intellectual disability, hypotonia and behavioral abnormalities. Journal of human genetics. 2014; 59(6): 300 - 306.
141. D'Adamo R, Welzl H, Papadimitriou S, di Barletta MR Tiveron C, Tatangelo L, et al. Deletion of the mental retardation gene Gdil impairs associative memory and alters social behavior in mice. Human Molecular Genetics. 2002; 11(21): 2567-2580.
142. Giannandrea M, Bianchi V, Mignogna ML, Sirri A Carrabino S, D'Elia E, et al. Mutations in the small GTPase gene RAB39B are responsible for X-linked mental retardation associated with autism, epilepsy, and macrocephaly. The American Journal of Human Genetics. 2010; 86(2): 185-195.
143. Weeber EJ, Levenson JM, Sweatt JD. Molecular genetics of human cognition. Molecular interventions. 2002; 2(6): 376.
144. Branchi I, Bichler Z, Minghetti L, Delabar JM, Malchiodi-Albedi F, Gonzalez MC, et al. Transgenic mouse in vivo library of human Down syndrome critical region 1: association between DYRK1A overexpression, brain development abnormalities, and cell cycle protein alteration. Journal of Neuropathology & Experimental Neurology. 2004; 63(5): 429 - 440.
145. O'Roak BJ, Vives L, Fu W, Egertson JD, Stanaway IB, Phelps IG, et al. Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science. 2012; 338(6114): 1619 - 1622.
146. Tielbeek JJ, Medland SE, Benyamin B, Byrne EM, Heath AC, Madden PA et al. Unraveling the genetic etiology of adult antisocial behavior: A genome-wide association study. PloS One. 2012; 7(10): e45086.
147. Ruaud L, Mignot C, Guët A, Ohl C, Nava C, Héron D, et al. DYRK1A mutations in two unrelated patients. European journal of Medical Genetics. 2015; 58(3): 168-174.
148. Van Bon B, Coe B, Bernier R Green C, Gerdts J, Witherspoon K, et al. Disruptive de novo mutations of DYRK1A lead to a syndromic form of autism and ID. Molecular psychiatry. 2015.
149. Vulto-van Silfhout AT, Rajamanickam S, Jensik PJ, Vergult S, De Rocker N, Newhall KJ, et al. Mutations affecting the SAND domain of DEAF1 cause intellectual disability with severe speech impairment and behavioral problems. The American Journal of Human Genetics. 2014; 94(5): 649-661.
150. Tarpey PS, Raymond FL, Nguyen LS, Rodriguez J, Hackett A Vandeleur L, et al. Mutations in UPF3B, a member of the nonsense-mediat- ed niRNA decay complex, cause syndromic and nonsyndromic mental retardation. Nature Genetics. 2007; 39(9): 1127 - 1133.
151. Laumonnier F, Nguyen LS, Jolly L, Raynaud M, Gecz J. UPF3B gene and nonsense-mediated niRNA decay in autism spectrum disorders. Comprehensive Guide to Autism: Springer; 2014; 1663 - 1678.
152. Jolly LA Homan CC, Jacob R, Barry S, Gecz J. The UPF3B gene, implicated in intellectual disability, autism, ADHD and childhood onset schizophrenia regulates neural progenitor cell behaviour and neuronal outgrowth. Human Molecular Genetics. 2013; 22(23): 4673 -4687.
153. Huang L, Shum EY, Karam R, Nguyen LS, Gecz J, Wilkinson MF. NMD-deficient Upf3b-null mice display behavioral and neuropathological defects. The FASEB Journal. 2012; 26(l_MeetingAbstracts): 747.5.
154. Shen E, Shulha H, Weng Z, Akbarian S. Regulation of histone H3K4 methylation in brain development and disease. Philosophical Transactions of the Royal Society of London B: Biological Sciences. 2014; 369(1652): 20130514.
155. Santos-Rebouças CB, Fintelman-Rodrigues N, Jensen LR Kuss AW, Ribeiro MG, Campos M, et al. A novel nonsense mutation in KD- M5C/JARID1C gene causing intellectual disability, short stature and speech delay. Neuroscience Letters. 2011; 498(1): 67-71.
156. Ounap K. Puusepp-Benazzouz H. Peters M. Vaher U. Rein R. Proos A et al. Anovel c. 2T> C mutation of the KDM5C/JARID1C gene in one large family with X-linked intellectual disability. European Journal of Medical Genetics. 2012; 55(3): 178 - 184.
157. Jensen LR. Anende M. Gurok U. Moser B. Gimmel V, Tzschach A, et al. Mutations in the JARID1C gene, which is involved in transcriptional regulation and chromatin remodeling, cause X-linked mental retardation. The American Journal of Human Genetics. 2005; 76(2): 227-236.
158. Gonçalves TF. Gonçalves AP. Rodrigues NF. dos Santos JM. Pimentel MMG. Santos-Rebouças CB. KDM5C mutational screening among males with intellectual disability suggestive of X-Linked inheritance and review of the literature. European Journal of Medical Genetics. 2014; 57(4): 138-144.
159. Reuter MS. Musante L. Hu H. Diederich S. Sticht H. Ekici AB. et al. NDST1 missense mutations in autosomal recessive intellectual disability. American Journal of Medical Genetics Part A. 2014; 164(11): 2753 - 2763.
160. Lenski C. Kooy RF. Reyniers E. Loessner D. Wanders RJ. Winnepen- ninckx B. et al. The reduced expression of the HADH2 protein causes X-linked mental retardation, choreoathetosis. and abnormal behavior. The American Journal of Human Genetics. 2007; 80(2): 372 - 377.